Claudia A M Stege

5PUBLICATIONS
29CO-AUTHORS
Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Feminist and queer theoryPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 25, 2025
Monitoring M-Protein, Therapeutic Antibodies, and Polyclonal Antibodies in a Multiparametric Mass Spectrometry Assay Provides Insight into Therapy Response Kinetics in Patients with Multiple Myeloma.

Charissa Wijnands, Peter G A Karel, Jolein Gloerich

|Jun 26, 2023
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.

Lina van der Straten, Claudia A M Stege, Sabina Kersting

|May 04, 2021
Ixazomib, Daratumumab, and Low-Dose Dexamethasone in Frail Patients With Newly Diagnosed Multiple Myeloma: The Hovon 143 Study.

Claudia A M Stege, Kazem Nasserinejad, Ellen van der Spek

|Apr 06, 2021
RE: Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study.

Joost Dekker, Claudia A M Stege, Kathelijn S Versteeg

|Feb 16, 2021
Improving the identification of frail elderly newly diagnosed multiple myeloma patients.

Claudia A M Stege, Kazem Nasserinejad, Saskia K Klein

Pageof 1

Frequent Collaborators

2 joint publications

Mark-David Levin

1 joint publications

Gerjo A Velders

1 joint publications

Joost Dekker

1 joint publications

Kathelijn S Versteeg